All Updates

All Updates

icon
Filter
Partnerships
Oxford Nanopore Technologies partners with Singapore's NPM for comprehensive genome sequencing project
Precision Medicine
Aug 5, 2024
This week:
Management news
6K Additive awarded project to develop C-103 powder for additive manufacturing
Additive Manufacturing
Sep 27, 2024
Partnerships
WAAM3D partners with Innovative Space Carrier, Cranfield University, and Aichi Sangyo for space transport development
Additive Manufacturing
Sep 19, 2024
Product updates
Microsoft launches Face Check with Microsoft Entra Verified ID
Facial Recognition
Sep 11, 2024
Funding
3DEO raises USD 3.5 million in strategic investment from Mizuho Bank
Additive Manufacturing
Sep 6, 2024
Product updates
HyperWrite launches open-source AI model Reflection 70 billion
Generative AI Applications
Sep 5, 2024
Product updates
Google begins US rollout of AI-powered Ask Photos feature
Generative AI Applications
Sep 5, 2024
Funding
Management news
HDAX Therapeutics raises USD 3.2 million in seed funding to progress pipeline and advance preclinical candidates into trials
Precision Medicine
Sep 5, 2024
Partnerships
Sequentify partners with Dexter to expand genomic diagnostics in Romania
Precision Medicine
Sep 5, 2024
Partnerships
Elevate partners with Cultivatd for European expansion
Vertical Farming
Sep 5, 2024
Product updates
Moolec confirms harvest of its genetically engineered plant-grown products
Crop Biotech
Sep 5, 2024
Precision Medicine

Precision Medicine

Aug 5, 2024

Oxford Nanopore Technologies partners with Singapore's NPM for comprehensive genome sequencing project

Partnerships

  • Oxford Nanopore Technologies has collaborated with Singapore's National Precision Medicine Programme led by Precision Health Research, Singapore (PRECISE), to study human genetic diversity and diseases.

  • Oxford Nanopore’s contribution to the project involves sequencing 10,000 genomes from Singapore’s diverse population, including Malay, Indian, and Chinese communities within the PRECISE-SG100K population cohort. Utilizing its high-output PromethION 48 sequencing devices, Oxford Nanopore aims to provide detailed, comprehensive genomic data to enhance research and support precision healthcare. The project commenced in mid-2024 and is expected to span up to 12 months.

  • Analyst QuickTime: In July 2024 , Oxford Nanopore Technologies partnered with Plasmidsaurus, a whole-plasmid sequencing provider, to expand the plasmid sequencing industry further. The partnership aimed to leverage Oxford Nanopore’s technology to overcome the limitations of traditional plasmid sequencing methods, such as Sanger, which were limited by short read lengths and primer dependency and are confounded by GC-rich or repetitive DNA.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.